Company File · BSE 500257 · Latest filing Q1 FY27
Standalone = this company only. Consolidated = including its subsidiaries.
Lupin Ltd
Data as of 19 Oct 2026 close · BSE · Latest results Q1 FY27
ISIN INE326A01037 · LUPIN · Healthcare › Pharmaceuticals & Biotechnology
About the business
What does Lupin do? It is a large Mumbai-based drug maker. It sells generic medicines in the US, including complex inhalers & injectables, branded medicines in India for heart, diabetes & breathing conditions, & medicines in other markets. It also makes active pharmaceutical ingredients (APIs). What is an API? The key chemical ingredient that makes a medicine work.
Price & valuation · BSE close, 19 Oct 2026
Below its usual level
- Sales growth
- +32.0%
- Profit growth
- +16.0%
- Op. margin
- 29.6%
- P/E
- 16.1×
- Usual P/E
- 22.0×
- Price/book
- 3.97×
- ROCE
- 28.8%
- ROE
- 26.9%
- Debt/equity
- 0.26×
- Promoter
- 46.85%
- Pledged
- 0.00%
The latest earnings call · Apr to Jun 2026 · transcript filed 12 Aug 2026
The transcript is ready to read; its call notes appear here once they are written.
Is it expensive, and is it a good business?
Key ratios
In short Priced below its own usual level (P/E 16.1× vs 22.0×), earns high returns on capital (ROCE 28.8%) and has modest borrowings (debt to equity 0.26×).
What you pay Valuation
Buyers pay about ₹16 for every ₹1 the company earned per share over the last year. Below its 1-year median of 22.0×.
Latest BSE close ÷ last four quarters' basic EPS. Uses earnings per share from continuing operations, so a one-off gain from selling a business does not flatter it. As of 19th October 2026.
The share price is 4.0 times the accounting value of each share. Below its 1-year median of 5.0×.
Latest BSE close ÷ book value per share (equity ÷ shares) on the latest balance-sheet date. As of 19th October 2026.
The market values the company at 3.0 times its yearly sales.
Market value ÷ last 12 months' revenue. As of 19th October 2026.
The whole business (shares plus debt, minus cash) is valued at about 9.4 years of its operating profit.
Enterprise value ÷ last 12 months' EBITDA. As of 19th October 2026.
The P/E of 16.1 divided by EPS growth of 62.3% (the latest financial year vs the year before). Below 1 is often read as cheap for the growth; above 2 as expensive.
P/E ÷ 12-month EPS growth in % (the last four quarters vs the four before; when those are not all held, the latest financial year vs the year before). Growth above 100% counts as 100%; left blank when EPS fell or was below ₹1 a share a year earlier. Without one-off items when either year has large ones, as for the P/E. As of 19th October 2026.
The company paid ₹18.00 a share in the last 12 months (1 payout), 0.92% of today's share price.
Dividends per share with an ex-date in the last 12 months (restated for any split or bonus since) ÷ the latest BSE close. As of 19th October 2026.
How well it uses money Returns & strength
Each ₹100 of shareholders' money and debt earned about ₹28.8 before interest & tax.
Last 12 months' profit before interest & tax ÷ average (equity + borrowings). As of 31st March 2026.
For every ₹100 of shareholders' money, the company earned about ₹26.9 in a year.
Last 12 months' profit after tax (continuing operations where reported) ÷ average equity. As of 31st March 2026.
The money actually tied up in running the business (leaving out spare cash) earned about 27.1% after tax.
Last 12 months' operating profit after tax (profit before interest & tax × (1 − effective tax rate)) ÷ average invested capital (equity + borrowings − cash & bank balances). As of 31st March 2026.
Every ₹1 of assets generated about ₹0.83 of sales in a year.
Last 12 months' revenue ÷ average total assets. As of 31st March 2026.
Operating profit covered interest costs about 18 times.
Last 12 months' profit before interest & tax ÷ finance costs. As of 30th June 2026.
For every ₹1 of shareholders' money, it has borrowed ₹0.26.
Borrowings ÷ shareholders' equity on the latest balance-sheet date. As of 31st March 2026.
Who owns it Ownership & more
The founders or parent group own 46.85% of the company.
Promoter & promoter group shareholding from the latest shareholding pattern filed with BSE. As of 30th June 2026.
Promoter holding fell by 0.01 percentage points last quarter.
Latest quarter's promoter holding minus the previous quarter's. As of 30th June 2026.
Promoter holding, quarter by quarter
- Jun 202646.85%
- Mar 202646.86%
- Dec 202546.89%
- Sep 202546.90%
Promoters reported no pledged shares.
Promoter group shares pledged ÷ all the promoter group's shares, from the shareholding pattern filed with BSE each quarter (other encumbrances, such as non-disposal undertakings, are not counted). As of 30th June 2026.
Pledged, quarter by quarter
- Jun 20260.00%
- Mar 20260.00%
- Dec 20250.00%
- Sep 20250.00%
After paying for new plant & equipment, operations left ₹5,491 crore of cash.
Cash from operations − spending on plant & equipment, latest full year. As of 31st March 2026.
Free cash flow, year by year
- FY26₹5,491 Cr
- FY25₹-1,252 Cr
Each share has a face (nominal) value of ₹2. It matters for dividends quoted as a percentage, not for valuation.
Face value per share as BSE lists it today.
About 45.73 crore shares were in issue.
BSE's count of listed shares (BSE's market cap ÷ its price), so splits, bonuses & new shares since the latest results are included. As of 19th October 2026.
Your ratios
Ratios you added. Your choices are remembered on this device.
The stock market values the company at about ₹89,343 crore.
Latest BSE close × BSE's count of listed shares. As of 19th October 2026.
Buying the whole business, including its debt and keeping its cash, would cost about ₹89,600 crore.
Market value + borrowings − cash & bank balances. As of 19th October 2026.
The company reported ₹5,551 crore of profit over the last four quarters.
Sum of the last four quarters' reported profit after tax. As of 30th June 2026.
Each share earned about ₹121.01 over the last year.
Sum of the last four quarters' basic EPS. Uses earnings per share from continuing operations, so a one-off gain from selling a business does not flatter it. As of 30th June 2026.
Each share is backed by about ₹492 of net assets on the books.
Shareholders' equity ÷ shares. As of 31st March 2026.
About ₹31.8 of every ₹100 of sales was left after running costs.
EBITDA ÷ revenue over the last four quarters. As of 30th June 2026.
About ₹17.1 of every ₹100 of sales became profit last quarter.
Profit after tax ÷ revenue for the latest quarter. As of 30th June 2026.
Sales were 32.0% higher than a year earlier.
Latest quarter's revenue vs the same quarter last year. As of 30th June 2026.
Profit was 16.0% higher than a year earlier.
Latest quarter's profit after tax vs the same quarter last year (continuing operations when a one-off discontinued item exists). As of 30th June 2026.
Short-term assets cover short-term bills 1.90 times.
Current assets ÷ current liabilities. As of 31st March 2026.
Customers take about 86 days to pay.
Trade receivables ÷ last 12 months' revenue × 365. As of 31st March 2026.
Stock on hand equals about 79 days of sales.
Inventories ÷ last 12 months' revenue × 365. As of 31st March 2026.
6.4% of pre-tax profit came from other income (interest, dividends, gains).
Other income ÷ profit before tax, last 12 months. As of 30th June 2026.
Each ₹1 of profit brought in ₹1.41 of operating cash.
Latest full year's cash from operations ÷ profit after tax. As of 31st March 2026.
Borrowings exceed cash by ₹257 crore.
Cash & bank balances − borrowings. As of 31st March 2026.
The company paid about 25.7% of its pre-tax profit as tax.
Tax expense ÷ profit before tax (continuing operations), last 12 months. As of 30th June 2026.
Everything the company owns earned 15.9% in a year.
Last 12 months' profit ÷ average total assets. As of 31st March 2026.
Operating profit before interest, depreciation & tax was ₹9,538 crore.
Revenue − expenses + finance costs + depreciation, last four quarters. As of 30th June 2026.
Needs five financial years of cash flows.
Sum over five financial years of (cash from operations − capital expenditure).
The company spent ₹2,055 crore on plant & equipment.
Purchase of property, plant & equipment, latest full year. As of 31st March 2026.
Borrowings stood at ₹5,910 crore.
Current + non-current borrowings. As of 31st March 2026.
Foreign institutions own 22.42%.
Foreign institutional holding from the latest shareholding pattern. As of 30th June 2026.
Domestic institutions own 24.65%.
Domestic institutional holding (mutual funds, insurers, banks, pension funds). As of 30th June 2026.
The highest price in the last year was ₹2,530.
Highest intraday BSE price in the last 12 months (raw, not adjusted). As of 16th July 2026.
The lowest price in the last year was ₹1,900.3.
Lowest intraday BSE price in the last 12 months (raw, not adjusted). As of 28th October 2025.
The share price moved 0.5% over the last year.
Close today ÷ close a year ago − 1 (raw prices, dividends not included). As of 19th October 2026.
About 15% of the last year's earnings per share was paid out as dividends.
Dividends per share with an ex-date in the last 12 months ÷ the last four quarters' EPS. As of 30th June 2026.
Needs four financial years of results (three years of growth).
Compound annual growth in revenue over three financial years.
Needs four financial years of results (three years of growth).
Compound annual growth in profit after tax over three financial years.
Tap the i beside any ratio for a plain explanation.
How these are worked out
Price-based ratios use the latest BSE close (19th October 2026). Share count 45.73 crore, from paid-up capital in the 19th October 2026 filing. Figures are consolidated.
What you pay: Higher numbers mean you pay more for each rupee the company earns or owns.
How well it uses money: Higher returns mean each rupee in the business earns more. Lower debt means less strain.
Who owns it: A steady promoter stake with nothing pledged is a calm sign.
+ Add your own ratios
Your choices are remembered on this device.
Last 4 quarters ₹ crore · Consolidated
| ₹ crore | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|
| Revenue from operations | 7,048 | 7,168 | 7,475 | 8,277 |
| EBITDA | 2,341 | 2,262 | 2,486 | 2,450 |
| Operating margin | 33.2% | 31.6% | 33.3% | 29.6% |
| One-off items | – | −426.6 | −131.3 | – |
| Profit after tax | 1,485 | 1,181 | 1,469 | 1,417 |
| Profit after tax without one-offs | 1,485 | 1,500 | 1,567 | 1,417 |
| Basic EPS (₹) | 32.36 | 25.74 | 31.96 | 30.95 |
One-off items: exceptional items reported separately in the filing. Profit without one-offs takes them out after tax at 25%.
Latest filings BSE
Corporate announcements 17
- 19 Oct 2026Allotment of ESOP / ESPS
- 15 Oct 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- ESG Rating
- 8 Oct 2026Press Release / Media Release
Quarterly results 4
- 19 Oct 2026Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026.
- 6 Aug 2026Press Release / Media Release
- 6 Aug 2026Board Meeting Outcome For Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
Conference calls 5
- 19 Oct 2026Analyst / Investor Meet - Intimation
- 8 Sep 2026Analyst / Investor Meet - Intimation
- 12 Aug 2026Earnings Call TranscriptOpens the call notes & transcript
Investor presentations 2
- 7 Aug 2026Investor Presentation
- 6 Aug 2026Investor Presentation
Members see every filing, and what each means for the company in Corporate Intelligence.
The full Company File
- Price, P/E, P/B & returns charts
- Growth vs last year, explained
- Cash from operations vs profit
- Accounts checks
- Who owns it
- 8 quarters, balance sheet & cash flow
- Every BSE filing, in four panels
- Excel & CSV downloads
Education & analysis only, not investment advice or a recommendation.